The Boston Globe takes a look at Knome, the consumer genomic company that sequences its customers' genomes while rounding up the challenges facing the field -- those cease-and-desist letters and the debate over medical relevance. The writer, Scott Kirsner, asks Raju Kucherlapati and David Altshuler if they'd get their genomes sequenced.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.